Coordinated Reset Deep Brain Stimulation
← catalyst calendarSponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Non randomized · Single · Treatment
Enrollment
15actual
Sites
2
Country
Germany
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2019-01-13 | actual | When the study began enrolling |
| Primary completion | 2025-11-12 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-11-12 | actual | The whole study's end, after follow-up |
| First posted | 2018-11-07 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-12-11 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Parkinson's Disease (PD)
Interventions
- Device: Novel Programming (nDBS)
- Device: Conventional Programming (cDBS)
Primary outcome
what the primary-completion date above is the date OFImprovement in Quality of Life using new programming paradigm: PDQ-39
measured approximately 4 weeks
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed